HonCode

Go Back   HER2 Support Group Forums > Breast Cancer Newsfeed
Register Gallery FAQ Members List Calendar Today's Posts

 
 
Thread Tools Display Modes
Prev Previous Post   Next Post Next
Old 06-11-2012, 10:10 AM   #1
News
Senior Member
 
News's Avatar
 
Join Date: Oct 2007
Posts: 18,959
Perjeta For Breast Cancer Gets Roche's Genentech An FDA Approval

Last week, Roche and Genentech announced results from its Phase III trial of trastuzumab emtansine (T-DM1) which slows progress of metastatic breast cancer, they hope to have FDA approval later in the year. In further news, Perjeta, also for treating breast cancer, has been given FDA approval also for treating HER2-postive late-stage (metastatic) breast cancer...

More...
News is offline   Reply With Quote
 


Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off

Forum Jump


All times are GMT -7. The time now is 06:05 PM.


Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021
free webpage hit counter